On February 6, however, FDAs approach appeared to shift with an announcement that it would be taking steps both to restrict GLP-1 active pharmaceutical ingredients (APIs) that continue to be used in non-FDA-approved compounded products to combat misleading direct-to-consumer advertising and marketing. Unequivocally, FDA warned: Entities engaged in the manufacture, distribution, or marketing of unapproved compounded GLP-1 products should be aware that failure to adequately address any violations may result in legal action without further notice, including, without limitation, seizure and injunction. FDA specifically named Hims & Hers a popular and outspoken telehealth provider that advertises compounded GLP-1 products in the announcement
10.1089/ars.2013.5371 107 PassosJ
In those situations, clinician-prescribed injectables studied and approved for weight management are usually the safer, better-supported option
the HFD group mainly concentrated on metabolites like betaine, phenylalanine, and taurine
Contact your GP if nausea is severe or persistent
I see positives in terms of mental health for some people